A Community Pharmacist-led Intervention to Improve Adherence to Lipid-lowering Treatment

Summary

The objective of the study is to test the effectiveness of a community pharmacist-led intervention to increase adherence to lipid lowering treatment.

Conditions

• Hypercholesterolemia

Interventions

BEHAVIORAL

advanced adherence counseling+reminder

DEVICE

Compliance Card

Sponsors & Collaborators

• Service Apotheek BV

  collaborator UNKNOWN

• Harvard University

  collaborator OTHER

• Department of Clinical Pharmacy, University Medical Centre St Radboud, The Netherlands.

  collaborator OTHER

• Scientific Institute for Dutch Pharmacists, The Netherlands

  collaborator OTHER

• Federation of Patients and Consumer Organisations in the Netherlands

  collaborator UNKNOWN

• Utrecht Institute for Pharmaceutical Sciences

  lead OTHER

Principal Investigators

• Boris LG Van Wijk, PharmD, PhD · Department of Pharmacoepidemiology & Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University

• Anthonius De Boer, MD, PhD · Department of Pharmacoepidemiology & Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University

• Olaf H Klungel, PharmD, PhD · Department of Pharmacoepidemiology & Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University

• William H Shrank, MD, MSHS · Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston

• Peter AG De Smet, PharmD, PhD · Scientific Institute of Dutch Pharmacists, The Hague

• Eibert R Heerdink, PhD · Department of Pharmacoepidemiology & Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University

• Emma Giesen, PharmD · Service Apotheek BV

• Marnix Westein, PharmD · Federation of Patients and Consumer Organisations in the Netherlands, Utrecht, The Netherlands

• Martina Teichert, PharmD · Scientific Institute of Dutch Pharmacists, The Hague, The Netherlands

Study Design

Allocation

RANDOMIZED

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

65 Years

Max Age

90 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2008-05-31

Primary Completion

2010-03-31

Completion

2010-03-31

Countries

• Netherlands

Study Locations